Zhong Chen

4.3k total citations
169 papers, 3.0k citations indexed

About

Zhong Chen is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhong Chen has authored 169 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 36 papers in Cancer Research and 24 papers in Surgery. Recurrent topics in Zhong Chen's work include MicroRNA in disease regulation (17 papers), Urinary Bladder and Prostate Research (16 papers) and Cancer-related molecular mechanisms research (15 papers). Zhong Chen is often cited by papers focused on MicroRNA in disease regulation (17 papers), Urinary Bladder and Prostate Research (16 papers) and Cancer-related molecular mechanisms research (15 papers). Zhong Chen collaborates with scholars based in China, United States and Japan. Zhong Chen's co-authors include Carter Van Waes, Zhijun Han, Wei Li, Kai Cui, Zhangqun Ye, Long‐Cheng Li, Mengyang Zhang, Chenghe Wang, Elena Loukinova and Lisa Gangi and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Zhong Chen

160 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhong Chen China 31 1.4k 591 362 348 315 169 3.0k
Jie Xia China 31 1.7k 1.2× 425 0.7× 325 0.9× 341 1.0× 372 1.2× 147 2.9k
Çığır Biray Avcı Türkiye 29 1.5k 1.1× 769 1.3× 503 1.4× 298 0.9× 236 0.7× 169 3.0k
Bin Xiao China 31 1.9k 1.3× 801 1.4× 339 0.9× 204 0.6× 254 0.8× 163 3.3k
Michał Nowicki Poland 28 1.5k 1.1× 532 0.9× 712 2.0× 275 0.8× 375 1.2× 253 3.5k
Ji‐Cheng Li China 33 1.5k 1.1× 586 1.0× 301 0.8× 231 0.7× 399 1.3× 200 3.4k
Ni Tang China 34 2.4k 1.7× 850 1.4× 476 1.3× 481 1.4× 292 0.9× 130 4.1k
Shu-Jen Chen Taiwan 31 2.1k 1.5× 943 1.6× 360 1.0× 397 1.1× 304 1.0× 59 4.0k
Masaki Miyazawa Japan 26 1.1k 0.8× 548 0.9× 256 0.7× 602 1.7× 273 0.9× 87 2.6k
Bei Xu China 31 1.4k 1.0× 537 0.9× 288 0.8× 247 0.7× 276 0.9× 164 3.6k
Fang Peng China 34 2.0k 1.4× 688 1.2× 556 1.5× 356 1.0× 214 0.7× 183 3.6k

Countries citing papers authored by Zhong Chen

Since Specialization
Citations

This map shows the geographic impact of Zhong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong Chen more than expected).

Fields of papers citing papers by Zhong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong Chen. The network helps show where Zhong Chen may publish in the future.

Co-authorship network of co-authors of Zhong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong Chen. A scholar is included among the top collaborators of Zhong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong Chen. Zhong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhong, Kang Yang, Yu Li, et al.. (2025). Advancements in Surgical Therapies for Drug-Resistant Epilepsy: A Paradigm Shift towards Precision Care. Neurology and Therapy. 14(2). 467–490.
2.
He, Yanqing, Tao Lu, Ying Wang, et al.. (2025). Beyond mTOR: Unraveling the Complex Pathophysiology and Signaling Pathways in Focal Cortical Dysplasia. Molecular Neurobiology. 63(1). 171–171.
3.
Chen, Zhong, et al.. (2025). β-hydroxybutyrate attenuates diabetic renal and muscular pathologies in a streptozotocin-induced diabetic model. Nutrition. 137. 112792–112792. 1 indexed citations
4.
Liu, Jiming, Guochun Zhao, Yuanyuan Xu, et al.. (2025). Genetic diversity and adaptive evolutionary history of Sapindus in China: insights from whole‐genome resequencing of 100 representative individuals. Plant Biotechnology Journal. 23(7). 2485–2500.
5.
Huang, P.C., et al.. (2025). Machine learning analysis identified NNMT as a potential therapeutic target for hepatocellular carcinoma based on PCD-related genes. Scientific Reports. 15(1). 7494–7494. 1 indexed citations
7.
Wen, Lei, et al.. (2025). Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis. Journal of Integrative Medicine. 23(4). 357–369. 2 indexed citations
9.
Zhou, Quan, et al.. (2024). Research and practice of telemedicine in urodynamic study. 57–62. 1 indexed citations
10.
Wu, Xiaoliang, Ruixin Fan, Yangjun Zhang, et al.. (2024). The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment. Clinical and Experimental Medicine. 24(1). 191–191. 1 indexed citations
11.
Zhou, Quan, Guang Li, Kai Cui, et al.. (2024). Using machine learning to construct the diagnosis model of female bladder outlet obstruction based on urodynamic study data. Investigative and Clinical Urology. 65(6). 559–559. 2 indexed citations
12.
Zhang, Yucong, et al.. (2024). Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis. Systematic Reviews. 13(1). 93–93. 1 indexed citations
13.
Liu, Zhicheng, Dongxu Lin, Yi Zhou, et al.. (2022). Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma. Scientific Reports. 12(1). 13222–13222. 2 indexed citations
14.
Chen, Huaijun, Chaoran Xu, Qian Yu, et al.. (2020). Comprehensive landscape of STEAP family functions and prognostic prediction value in glioblastoma. Journal of Cellular Physiology. 236(4). 2988–3000. 49 indexed citations
15.
Chen, Zhong, et al.. (2016). Effect of P120(ctn) Silence and Overexpression on Cell Migration and Invasion of Oral Squamous Cell Carcinoma. 32(11). 1145. 1 indexed citations
16.
Wang, Xiuxing, Jiang Chen, Na Xu, et al.. (2015). MILI, a PIWI family protein, inhibits melanoma cell migration through methylation of LINE1. Biochemical and Biophysical Research Communications. 457(4). 514–519. 7 indexed citations
17.
Zhang, Miaomiao, Yanli Liu, Zhong Chen, et al.. (2012). A New Triterpenoid Saponin from Aidi Injection. Chinese Herbal Medicines. 4(2). 84–86. 3 indexed citations
18.
Arun, Pattatheyil, Matthew S. Brown, Reza Ehsanian, Zhong Chen, & Carter Van Waes. (2009). Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer. Clinical Cancer Research. 15(19). 5974–5984. 57 indexed citations
19.
Chen, Zhong, Robert F. Place, Zhejun Jia, et al.. (2008). Antitumor effect of dsRNA-induced p21WAF1/CIP1 gene activation in human bladder cancer cells. Molecular Cancer Therapeutics. 7(3). 698–703. 79 indexed citations
20.
Yang, Weimin, et al.. (2000). Correlative expression of glutathion S-Transferase-π and multidrug resistance associated protein in bladder transitional cell carcinoma. Current Medical Science. 20(4). 311–314. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026